EXAMINE THIS REPORT ON HEMGENIX

Number of suitable patients: CDEC discussed the uncertainty in the number of individuals with moderately severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who're classified as getting mild or average sickness could possibly have a critical bleeding ph